↓ Skip to main content

Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

Overview of attention for article published in Journal of Clinical Oncology, December 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news
4 news outlets
twitter
33 X users
podcasts
1 podcast

Readers on

mendeley
127 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 33 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 127 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 17 13%
Researcher 16 13%
Student > Bachelor 11 9%
Student > Ph. D. Student 10 8%
Student > Master 5 4%
Other 18 14%
Unknown 50 39%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 44 35%
Biochemistry, Genetics and Molecular Biology 11 9%
Nursing and Health Professions 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Immunology and Microbiology 2 2%
Other 10 8%
Unknown 53 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 55. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#896,046
of 29,498,312 outputs
Outputs from Journal of Clinical Oncology
#2,236
of 27,446 outputs
Outputs of similar age
#19,177
of 494,326 outputs
Outputs of similar age from Journal of Clinical Oncology
#38
of 188 outputs
Altmetric has tracked 29,498,312 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 27,446 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 494,326 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 188 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.